Thermomind

Early-stage Breast Cancer Detection

Health Tech & Life Sciences
Active
Pre-Seed Haifa Founded 2022
Total raised
$12.6M
Last: Pre-Seed 2021-08
Stage
Pre-Seed
Founded
2022
Headcount
1
HQ
Haifa
Sector
Health Tech & Life Sciences

About

ThermoMind is a cutting-edge technology company that is revolutionizing the healthcare industry by offering advanced thermal imaging solutions. Using the latest in thermal sensing technology and artificial intelligence, the company is dedicated to providing highly accurate and reliable imaging technologies that can help doctors and medical professionals make more informed decisions about patient care.

The company develops medical devices with customized, highly sensitive thermal sensing hardware and combines with sophisticated AI system to analyze thermal data and identify potential health issues in patients. Whether it's for early disease detection, real-time monitoring, or ongoing patient care, the company's imaging solutions offer unparalleled accuracy and reliability. The current target of the company is transforming the way breast cancer is detected and diagnosed, by a next-generation non-contact and radiation-free screening modality for breast cancer detection. The core of the technology is the advanced AI analysis which is set to identify metabolic abnormalities within the breast indicating breast cancer.

The startup's screening modality is designed to be highly scalable, efficient, and cost-effective, making it accessible to a wide range of patients and healthcare providers. By eliminating the need for radiation and contact-based screening methods, the company's technology offers a safer and more comfortable screening experience for patients, while also reducing the risk of false positives and unnecessary biopsies.

Funding history · 1 round · $12.6M total

2021-08
Pre-Seed $620K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Thermomind's primary focus in the healthcare industry?
Thermomind is focused on revolutionizing the healthcare industry by offering advanced thermal imaging solutions, specifically targeting early-stage breast cancer detection.
What technology does Thermomind utilize for its breast cancer detection solution?
Thermomind develops medical devices that combine customized, highly sensitive thermal sensing hardware with a sophisticated AI system to analyze thermal data and identify potential health issues, particularly metabolic abnormalities indicating breast cancer.
When was Thermomind founded?
Thermomind was founded in April 2022.
How many employees does Thermomind currently have?
Thermomind currently has between 1 and 10 employees.
What was Thermomind's last funding round, and when did it occur?
Thermomind's last funding round was a Pre-Seed round in August 2021, raising $620,000.
Has Thermomind received any grants, and if so, from whom and for how much?
Yes, Thermomind received a grant of $12,000,000 from the IIA in August 2022.
What is the current product stage of Thermomind's THERMOBREAST solution?
The THERMOBREAST product is currently in the clinical trial stage.
Who are the co-founders of Thermomind?
The co-founders of Thermomind are Najeeb Ayoub and Larisa Adamyan.
In which geographic markets does Thermomind have a presence?
Thermomind has a presence in the United Arab Emirates, Europe, Israel, the United States, and the Americas.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial IntelligenceSensingInfrared
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2G

Highlights

1 PatentsVerified

Tags

cancerwomen-healthmedical-technologiesnon-invasiveearly-detectiondigital-healthcareartificial-intelligencemedical-devicesfemtechcancer-diagnostics